These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 70173)

  • 1. Isolation from human serum of an inactivator of bacterial lipopolysaccharide.
    Johnson KJ; Ward PA; Goralnick S; Osborn MJ
    Am J Pathol; 1977 Sep; 88(3):559-74. PubMed ID: 70173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two distinct chemotactic factor inactivators in human serum.
    Till G; Ward PA
    J Immunol; 1975 Feb; 114(2 pt 2):843-7. PubMed ID: 46254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of endotoxin response by e5564, a novel Toll-like receptor 4-directed endotoxin antagonist.
    Mullarkey M; Rose JR; Bristol J; Kawata T; Kimura A; Kobayashi S; Przetak M; Chow J; Gusovsky F; Christ WJ; Rossignol DP
    J Pharmacol Exp Ther; 2003 Mar; 304(3):1093-102. PubMed ID: 12604686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New function for high density lipoproteins. Their participation in intravascular reactions of bacterial lipopolysaccharides.
    Ulevitch RJ; Johnston AR; Weinstein DB
    J Clin Invest; 1979 Nov; 64(5):1516-24. PubMed ID: 227936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of collagen-induced platelet aggregation by normal plasma.
    Nossel HL; Wilner GD; Drillings M
    J Clin Invest; 1971 Oct; 50(10):2168-75. PubMed ID: 4107268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A synthetic lipopolysaccharide-binding peptide based on amino acids 27-39 of serum amyloid P component inhibits lipopolysaccharide-induced responses in human blood.
    de Haas CJ; van der Tol ME; Van Kessel KP; Verhoef J; Van Strijp JA
    J Immunol; 1998 Oct; 161(7):3607-15. PubMed ID: 9759883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Binding studies of radioactive lipopolysaccharide with Limulus amebocytes.
    Rickles FR; Rick PD; Armstrong PB; Levin J
    Prog Clin Biol Res; 1979; 29():203-7. PubMed ID: 504253
    [No Abstract]   [Full Text] [Related]  

  • 8. A synthetic peptide derived from bactericidal/permeability-increasing protein neutralizes endotoxin in vitro and in vivo.
    Jiang Z; Hong Z; Guo W; Xiaoyun G; Gengfa L; Yongning L; Guangxia X
    Int Immunopharmacol; 2004 Apr; 4(4):527-37. PubMed ID: 15099530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A synthetic cyclic peptide derived from Limulus anti-lipopolysaccharide factor neutralizes endotoxin in vitro and in vivo.
    Ren JD; Gu JS; Gao HF; Xia PY; Xiao GX
    Int Immunopharmacol; 2008 Jun; 8(6):775-81. PubMed ID: 18442780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bartonella quintana lipopolysaccharide effects on leukocytes, CXC chemokines and apoptosis: a study on the human whole blood and a rat model.
    Matera G; Liberto MC; Quirino A; Barreca GS; Lamberti AG; Iannone M; Mancuso E; Palma E; Cufari FA; Rotiroti D; Focà A
    Int Immunopharmacol; 2003 Jun; 3(6):853-64. PubMed ID: 12781702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interactions of bacterial lipopolysaccharide with acute-phase rabbit serum and isolation of two forms of rabbit serum amyloid A.
    Tobias PS; McAdam KP; Ulevitch RJ
    J Immunol; 1982 Mar; 128(3):1420-7. PubMed ID: 7057038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bactericidal and endotoxin neutralizing activity of a peptide derived from Limulus antilipopolysaccharide factor.
    Weiss CA; Wasiluk KR; Kellogg TA; Dunn DL
    Surgery; 2000 Aug; 128(2):339-44. PubMed ID: 10923014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Limulus amebocyte lysate - a means to monitor inactivation of lipopolysaccharide.
    Tsuji K; Harrison SJ
    Prog Clin Biol Res; 1979; 29():367-78. PubMed ID: 504267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endotoxin evaluation of eleven lipopolysaccharides by whole blood assay does not always correlate with Limulus amebocyte lysate assay.
    Dehus O; Hartung T; Hermann C
    J Endotoxin Res; 2006; 12(3):171-80. PubMed ID: 16719988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Study of lipopolysaccharide antagonizing effect of DPR-2 in vitro].
    Guo YB; Cao HW; Chen LP; Lu YL; Zheng J; Xiao GX
    Zhonghua Shao Shang Za Zhi; 2007 Apr; 23(2):104-7. PubMed ID: 17649883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The heat sensitivity of cytokine-inducing effect of lipopolysaccharide.
    Gao B; Wang Y; Tsan MF
    J Leukoc Biol; 2006 Aug; 80(2):359-66. PubMed ID: 16720829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel endotoxin antagonist attenuates tumor necrosis factor-alpha secretion.
    Dahlberg PS; Acton RD; Battafarano RJ; Uknis ME; Ratz CA; Johnston JW; Haseman JR; Gray BH; Dunn DL
    J Surg Res; 1996 Jun; 63(1):44-8. PubMed ID: 8661170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The bactericidal/permeability increasing protein of neutrophils is a potent antibacterial and anti-endotoxin agent in vitro and in vivo.
    Elsbach P; Weiss J; Doerfler M; Shu C; Kohn F; Ammons WS; Kung AH; Meszaros KK; Parent JB
    Prog Clin Biol Res; 1994; 388():41-51. PubMed ID: 7831373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of TNF-triggering activity of lipopolysaccharide by a proteinaceous factor from normal mouse liver extract.
    Satoh M; Matsumura T; Nakamoto M; Yamazaki M
    J Immunol; 1995 Jul; 155(2):877-85. PubMed ID: 7608565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluid-phase SC5b-8 complex of human complement: generation and isolation from serum.
    Bhakdi S; Roth M
    J Immunol; 1981 Aug; 127(2):576-80. PubMed ID: 6166677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.